Pros and Cons of Virtual Care Solutions
Do the advantages of virtual care outweigh the drawbacks? Patients seem to think so.
Novel Immunotherapies Target RSV Disease at Both Ends of the Age Spectrum
RSV infections account for a large share of U.S. hospitalizations for lower respiratory tract disease due in large part to a lack of immunization and prophylactic therapies, but new developments and cutting-edge therapies may soon become standard medical practice.
Proposed Payment Systems and Fee Schedules in 2023
Proposed rules revising the Medicare Hospital Outpatient Prospective Payment System (OPPS) and the Medicare Ambulatory Surgical Center (ASC) services, along with new physician fee schedule (PFS) rule sets will significantly impact providers in 2023.
Myths & Facts: Depression
The best way to help individuals suffering from depression is to spread awareness about the misconceptions surrounding this mood disorder.
Vaccine Passports: Vaccination Confirmation or a Privacy Concern?
The implementation of vaccine passports in response to the COVID-19 pandemic has raised arguments for and against them.
Ryplazim: The First Definitive Treatment for Congenital Plasminogen Deficiency
An ultrarare autosomal recessive disorder, congenital plasminogen deficiency (PLGD) results from inheritance of defective copies of both alleles of the PLG gene, which yields dysfunctional or too little plasminogen. The end result is impaired extracellular fibrin clearance during wound healing, presenting on affected mucous membranes throughout the body as accumulations of nondegraded fibrin as pseudomembranous ligneous — “woody” — growths.
Myths & Facts: Melanoma
While the incidence of melanoma has stabilized over the past five years, the number of people diagnosed is still alarming.
Update on Treating PTSD
not a new condition, PTSD continues to affect many people who require new treatments to allow them to lead as normal a life as possible.
Immunity Debt: A Catalyst for the Development of Infections and Autoimmune Disease?
Are precautions to stop the spread of COVID-19 now causing other widespread illness?
The Promise of mRNA Vaccines for Disease Prevention
Using mRNA technology, the same science that developed mRNA COVID-19 vaccines, Pfizer and Moderna are testing multiple vaccines to prevent diseases that cause millions of deaths each year.
